-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Zenas BioPharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2023 to Q2 2025.
- Zenas BioPharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $6.05M, a 294% increase year-over-year.
- Zenas BioPharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $19.8M.
- Zenas BioPharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $10.8M, a 210% increase from 2023.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)